Tag: $Johnson and Johnson

Johnson & Johnson raised its full-year guidance on the back of better-than-expected second-quarter earnings as strength in its oncology portfolio helped offset falling sales for its former blockbuster drug, Stelara. Wall Street shrugged at the results.

Johnson & Johnson (JNJ) has reinvented itself several times in recent years. In 2021, it was best known as the developer of a Covid vaccine.

Johnson & Johnson had another strong quarter, driven by revenue growth of two important cancer drugs, but it also reported lower-than-expected net profit.

Johnson & Johnson has said it will lower the price of some medications sold to U.S. consumers, making it the latest pharmaceutical company to form a business agreement with the Trump administration.